Results 211 to 220 of about 17,677 (287)

Clinicopathological and transcriptomic profiles of 101 patients with diffuse large B‐cell lymphoma/high‐grade B‐cell lymphoma with double‐hit MYC and BCL2 or BCL6 and triple hit

Histopathology, Volume 88, Issue 7, Page 1324-1347, June 2026.
Diffuse large B‐cell lymphoma/high‐grade B‐cell lymphoma (DLBCL/HGBCL) is a mature aggressive B‐cell lymphoma. This article performed a comprehensive clinicopathological and transcriptomic analyses of this lymphoma category. Aims Diffuse large B‐cell lymphoma/high‐grade B‐cell lymphoma (DLBCL/HGBCL) with MYC and BCL2 rearrangements (double‐hit lymphoma
Masashi Miyaoka, Joaquim Carreras, Yara Yukie Kikuti, Haruka Ikoma, Shunsuke Nagase, Atsushi Ito, Makoto Orita, Hiroshi Kawada, Rika Sakai, Yasuharu Sato, Midori Filiz Nishimura, Kunihiro Tsukasaki, Shuji Momose, Yoshihiro Kameoka, Masahiro Yoshida, Akira Satou, Seiichi Kato, Naoki Oishi, Akio Saito, Ken Sadahira, Yohei Masugi, Naoya Nakamura   +21 more
wiley   +1 more source

A review of decomposition methods for brain states estimation. [PDF]

Biomed Eng Online
Hu G, Wang J, Shui Z, Wang T, Wang D, Luo S, Liu H, Xie X, Nickerson LD.   +8 more
europepmc   +1 more source

A Stimuli in the NMF and m-NMF condition of Study I and Study II

, 2020
openaire   +1 more source

Synergistic Skin Penetration Enhancement by a Combination of Tetrahydropiperine, 2,3‐Butanediol, and Hydrolyzed Glycosaminoglycans

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Effective and safe skin penetration enhancers are highly valuable for improving the efficacy of topical drug and cosmetic formulations. Objective This study aimed to develop and validate novel synergistic combinations of tetrahydropiperine (THP), 2,3‐butanediol (2,3‐BD), and hydrolyzed glycosaminoglycans (hGAGs) as effective skin ...
Bei Wang, Guojie Zhao, Jinghui Peng, Qiulan Ye, Xueping Chen   +4 more
wiley   +1 more source

Exploration of the roles of SSR2 in hepatocellular carcinogenesis based on single-cell transcriptomics and spatial transcriptomics. [PDF]

Discov Oncol
Liu S, Wang X, Cheng D, Hu K, Qin X.
europepmc   +1 more source

Predictive Biomarkers in Laser Dermatology: Toward Personalized Energy‐Based Treatments

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Despite major technological advances in laser and energy‐based devices, adverse events such as post‐inflammatory hyperpigmentation (PIH), prolonged erythema, delayed wound healing, and dyschromia remain significant clinical challenges.
Diala Haykal, Alexandre de Almeida Filippo, Gustavo Robertson Filippo, Marco Rocha, Ashraf Badawi   +4 more
wiley   +1 more source

MS-ConTab: multi-scale contrastive learning of mutation signatures for Pan-Cancer representation and stratification. [PDF]

Bioinformatics
Dou Y, Khadre A, Petreaca RC, Golrokh M.
europepmc   +1 more source

Reviving the Skin From Within: Mechanistic Insights Into a Well‐Tolerated Dermal Filler—CPM‐HA20G

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Dermal fillers composed of hyaluronic acid (HA) combined with glycerol have been clinically shown to enhance skin hydration and quality; the precise mechanisms underlying their efficacy have yet to be fully elucidated. Aims Investigation of the dual hydration mechanisms, cell protection and tolerability, and tissue compatibility of ...
Kay Marquardt, Christian Hartmann, Sonja Sattler, Je‐Young Park, Ting Song Lim, Luis Alberto Parra Hernandez, Christina Wollenburg, Daniela Schäfer, Sarah Hetier‐Jaccoud, Thomas Hengl   +9 more
wiley   +1 more source

Investigating the role of the TGF-β-SLC20A1 axis in the spatial heterogeneity of hepatocellular carcinoma through single-cell and spatial transcriptomics. [PDF]

Front Immunol
Li J, An J, Jiang S, Wang X, Zhang F, Liu J, Li W, Wang M, Wu X, Li S, Wang W, Yu T, Liu X, Li M.   +13 more
europepmc   +1 more source

Immune endotypes in tuberculosis: Keys to decoding disease complexity

Journal of Internal Medicine, Volume 299, Issue 6, Page 670-693, June 2026.
Abstract Tuberculosis (TB) remains a major global health challenge, with multi‐drug antibiotic regimens as the current standard of care. While effective at killing Mycobacterium tuberculosis, these treatments do not resolve persistent inflammation, prevent lung damage, or reverse immune dysregulation that contribute to poor outcomes and disease ...
Shamila D. Alipoor, Julia Guthrie, Lina Davies Forsman, Andrew R. Di Nardo, Susanna Brighenti   +4 more
wiley   +1 more source